Klausner Richard - Insider Non-Derivative Transactions at Lyell Immunopharma, Inc. (LYEL) - (SEC)
Updated on December 12, 2024.
According to recent SEC insider information filed on Aug 15, 2023, Klausner Richard's relationship to Lyell Immunopharma, Inc. (LYEL) is Director, and currently has 930,880 shares of Common Stock.
The chart below shows the number of shares owned, and the table shows the recent insider transactions.
You can see similar information for other LYEL insiders.
Data Source: SEC.
Klausner Richard - Insider Non-Derivative Transactions at LYEL
Items per page:
0 of 0
| Date | Transaction | No. of Shares | Price Per Share | Shares Owned After Transactions |
|---|---|---|---|---|
| Aug 16, 2023 | Sell -- (Common Stock) | 58020 | 2.28 | 930880 |